As OD16 is a BMPRI inhibitor and OD29 is a dual BMP and VEGF pathway inhibitor, their antagonistic activity on tumor-induced angiogenesis was assessed in a breast cancer xenograft model in zebrafish. This evidence concerns the gene VEGFA and breast cancer.